Automated Nucleic Acid Extraction Devices Market Developments and Growth Opportunities Across 2026–2030
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Automated Nucleic Acid Extraction Devices Market Between 2026 And 2030?
The automated nucleic acid extraction devices market has experienced rapid growth in recent years. It is expected to expand from $6.6 billion in 2025 to $7.32 billion in 2026, registering a compound annual growth rate (CAGR) of 10.9%. This past growth can be ascribed to factors like the expansion of molecular diagnostic testing, the rising incidence of infectious diseases, increased adoption of laboratory automation, an increase in clinical testing volumes, and advancements in nucleic acid chemistry.
The market for automated nucleic acid extraction devices is projected to experience swift expansion over the coming years, set to reach $11.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. Factors contributing to this anticipated growth include a heightened need for quick diagnostic methods, increased funding in genomic research, the broadening scope of personalized medicine testing, wider acceptance of point-of-care molecular diagnostics, and advancements in extraction efficiency technologies. Key developments expected during this forecast period encompass the increasing integration of fully automated extraction platforms, a surge in demand for high-throughput molecular diagnostics, the expanding application of integrated sample-to-result systems, the widening of automated laboratory workflows, and a greater emphasis on processing that is free from contamination.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9421&type=smp
What Drivers Are Influencing The Automated Nucleic Acid Extraction Devices Market?
The future expansion of the automated nucleic acid extraction devices market is anticipated to be fueled by the rising occurrence of infectious diseases. An infectious illness is defined as a condition resulting from pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, which can spread either directly or indirectly among individuals or from animals to humans. The escalation in infectious diseases, especially during worldwide health emergencies like pandemics, intensifies the demand for diagnostic testing. Automated nucleic acid extraction devices are crucial in preparing samples for molecular diagnostics, aiding in the identification of viruses and bacteria. For example, data from GOV.UK, a UK public sector information website, indicated in September 2023 that during the initial half of 2023, tuberculosis (TB) incidents in England saw a 7% increase relative to the corresponding period in 2022, with reported cases climbing from 2,251 to 2,408. Consequently, the escalating presence of infectious diseases is a primary catalyst for the expansion of the automated nucleic acid extraction devices market.
Which Market Segments Are Examined In The Automated Nucleic Acid Extraction Devices Market Study?
The automated nucleic acid extraction devices market covered in this report is segmented –
1) By Type: Instruments, Kits, Consumables
2) By Automation Level: Fully Automated, Semi-Automated
3) By End User: Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes
Subsegments:
1) By Instruments: Automated Extractors, Liquid Handling Systems
2) By Kits: DNA Extraction Kits, RNA Extraction Kits, Viral Nucleic Acid Extraction Kits
3) By Consumables: Reagents, Columns, Tips And Tubes
Which Trends Are Influencing The Automated Nucleic Acid Extraction Devices Market?
Leading companies in the automated nucleic acid extraction devices market are developing innovative products, such as automated nucleic acid extraction workstations, to attract larger customer bases, increase sales, and boost revenue. An automated nucleic acid extraction workstation is a specialized and automated system designed for the extraction of nucleic acids, including DNA and RNA, from biological samples. For instance, in April 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of in-vitro diagnostic products, launched the SAW-48 and Cell Nucleic Acid Extraction Kit (Magnetic Bead Method). The SAW-48 is a distinctive in-vitro diagnostic medical device that seamlessly integrates sample loading, nucleic acid purification, and PCR setup functions into a single instrument. This innovative device can concurrently process up to 48 samples, leading to a substantial reduction in the time required for obtaining test results. The SAW-48 streamlines the entire process of sample loading, nucleic acid purification, and PCR setup, enhancing the efficiency of STD and HPV detection. The SAW-48 and the Cell Nucleic Acid Extraction Kit contribute to a comprehensive solution, ensuring a more efficient and streamlined approach to the detection of sexually transmitted diseases and human papillomavirus.
Who Are The Primary Competitors In The Automated Nucleic Acid Extraction Devices Market?
Major companies operating in the automated nucleic acid extraction devices market are QIAGEN N.V., PerkinElmer Inc., F. Hoffmann-La Roche AG, Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Tecan Group Ltd., Merck KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Xi’an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., MicroGEM International Company, Norgen Biotek Corp.
Read the full automated nucleic acid extraction devices market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Automated Nucleic Acid Extraction Devices Market?
North America was the largest region in the automated nucleic acid extraction devices market in 2025. The regions covered in the automated nucleic acid extraction devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Automated Nucleic Acid Extraction Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=9421&type=smp
Browse Through More Reports Similar to the Global Automated Nucleic Acid Extraction Devices Market 2026, By The Business Research Company
Nucleic Acid Extraction Instruments And Reagents Market Report 2026
Nucleic Acid Labeling Market Report 2026
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
Dna Or Rna Sample Extraction And Isolation Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model